EUVIMEDEUVIMED entdecken
Open Access

The use of human iPSC‐derived alveolar organoids to explore SARS‐CoV‐2 variant infections and host responses

Chaitanya Gandikota iD, Kishore Vaddadi iD, Pulavendran Sivasami, Chaoqun Huang, Yurong Liang, Samuel Pushparaj, Xufang Deng, Rudragouda Channappanava, Jordan P Metcalf, Lin Liu iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Chaitanya Gandikota und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiological Sciences, The Lundberg-Kienlen Lung Biology and Toxicology Laboratory, Oklahoma State University, Stillwater, Oklahoma, U…. Hauptthemen laut MEDLINE: COVID-19, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome‐related coronavirus 2 (SARS‐CoV‐2) primarily targets the respiratory system. Physiologically relevant human lung models are indispensable to investigate virus‐induced host response and disease pathogenesis. In this study, we generated human induced pluripotent stem cell (iPSC)‐derived alveolar organoids (AOs) using an established protocol that recapitulates the sequential steps of in vivo lung development. AOs express alveolar epithelial type II cell protein markers including pro‐surfactant protein C and ATP binding cassette subfamily A member 3. Compared to primary human alveolar type II cells, AOs expressed higher mRNA levels of SARS‐CoV‐2 entry factors, angiotensin‐converting enzyme 2 (ACE2), asialoglycoprotein receptor 1 (ASGR1) and basigin (CD147). Considering the localization of ACE2 on the apical side in AOs, we used three AO models, apical‐in, sheared and apical‐out for SARS‐CoV‐2 infection. All three models of AOs were robustly infected with the SARS‐CoV‐2 irrespective of ACE2 accessibility. Antibody blocking experiment revealed that ASGR1 was the main receptor for SARS‐CoV2 entry from the basolateral in apical‐in AOs. AOs supported the replication of SARS‐CoV‐2 variants WA1, Alpha, Beta, Delta, and Zeta and Omicron to a variable degree with WA1 being the highest and Omicron being the least. Transcriptomic profiling of infected AOs revealed the induction of inflammatory and interferon‐related pathways with NF‐κB signaling being the predominant host response. In summary, iPSC‐derived AOs can serve as excellent human lung models to investigate infection of SARS‐CoV‐2 variants and host responses from both apical and basolateral sides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Induced Pluripotent Stem CellsHumansSARS-CoV-2Angiotensin-Converting Enzyme 2RNA, ViralLungOrganoidsAsialoglycoprotein Receptor

Stichwörter der Autor:innen

SARS coronavirusimmune responsesinnate immunitypathogenesisvirus classification

Substanzen

Angiotensin-Converting Enzyme 2RNA, ViralASGR1 protein, humanAsialoglycoprotein Receptor

Autor:innen und Institutionen

  • Department of Physiological Sciences, The Lundberg-Kienlen Lung Biology and Toxicology Laboratory, Oklahoma State University, Stillwater, Oklahoma, USA.
  • Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, Oklahoma, USA.
  • Department of Physiological Sciences, Oklahoma State University, Stillwater, Oklahoma, USA.
  • Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, Oklahoma, USA.
  • Pulmonary and Critical Care Division, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

ORCID-Profile: Chaitanya Gandikota, Kishore Vaddadi, Lin Liu

Förderung

  • BLRD VA
  • NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Gandikota, C., Vaddadi, K., Sivasami, P., Huang, C., Liang, Y., Pushparaj, S., Deng, X., Channappanava, R., Metcalf, J. P., & Liu, L. (2024). The use of human iPSC‐derived alveolar organoids to explore SARS‐CoV‐2 variant infections and host responses. Journal of Medical Virology. https://doi.org/10.1002/jmv.29579

Vancouver

Gandikota C, Vaddadi K, Sivasami P, Huang C, Liang Y, Pushparaj S, et al. The use of human iPSC‐derived alveolar organoids to explore SARS‐CoV‐2 variant infections and host responses. Journal of Medical Virology. 2024. doi:10.1002/jmv.29579

BibTeX
@article{Gandikota2024,
  author = {Gandikota, Chaitanya and Vaddadi, Kishore and Sivasami, Pulavendran and Huang, Chaoqun and Liang, Yurong and Pushparaj, Samuel and Deng, Xufang and Channappanava, Rudragouda and Metcalf, Jordan P and Liu, Lin},
  title = {The use of human iPSC‐derived alveolar organoids to explore SARS‐CoV‐2 variant infections and host responses},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29579}
}
Kostenlos starten →